Economic Impact Analysis: A Pocket-Sized Rapid, Multiplex PCR Diagnostic for Infection Testing for Self-Directed Healthcare

经济影响分析：用于自我指导医疗保健感染检测的袖珍快速多重 PCR 诊断

• 批准号: 10044453
• 金额: $ 6.37万
• 依托单位: LABREADY LTD
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10044453
• 关键词: Economic; Impact; Analysis; Pocket; Sized

LabReady is developing the world's first pocket-sized, rapid, multiplex qPCR test that allow GPs, nurses, A&E, and even patients to simultaneously diagnose five different treatable infections within 30 minutes and without millions of pounds of expensive equipment, skilled technicians, and lab delays. This proposed project aims to develop the economics analysis technical model and report of how a first-of-its-kind pocket sized and rapid, multiplex qPCR diagnostic technology like MyLabReady impacts target patient populations along a self-directed healthcare pathway. As a critical milestone of the commercialization process of deploying this innovative and much needed technology into a market like the English health and social care system, this project will conduct a study into the underlying technology's cost-effectiveness and impact, including an economic model, economic costs, and outcomes cost with an appropriate comparator.

LabReady正在开发世界上第一个袖珍、快速、多重qPCR测试，允许全科医生、护士、急诊室甚至患者在30分钟内同时诊断5种不同的可治疗感染，而不需要花费数百万英镑的昂贵设备、熟练的技术人员和实验室延误。这个拟议的项目旨在开发经济学分析技术模型和报告，以了解像MyLabReady这样的首个袖珍大小和快速的多路qPCR诊断技术如何影响自我导向的医疗保健路径上的目标患者群体。作为将这种创新和急需的技术部署到英国医疗和社会保健系统等市场的商业化进程的关键里程碑，该项目将通过适当的比较，对基础技术的成本效益和影响进行研究，包括经济模型、经济成本和结果成本。